BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 8157310)

  • 1. Sweat osmolality in some of the congenital diseases.
    Geetha H; Jayakeerthy CM
    Indian J Pathol Microbiol; 1993 Oct; 36(4):420-4. PubMed ID: 8157310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of sweat osmolality in the diagnosis of cystic fibrosis.
    Franckx J; Shmerling DH
    Helv Paediatr Acta; 1984 Oct; 39(4):347-53. PubMed ID: 6543847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sweat osmolality in Down's syndrome and cystic fibrosis in an Indian population.
    Geetha H; Shetty KT
    Br Med J (Clin Res Ed); 1987 Jan; 294(6565):156. PubMed ID: 2954606
    [No Abstract]   [Full Text] [Related]  

  • 4. Abnormally high sweat osmolality in children with Down's syndrome.
    Symon DN; Stewart L; Russell G
    J Ment Defic Res; 1985 Sep; 29 ( Pt 3)():257-61. PubMed ID: 2933525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative mortality in mentally retarded patients in California, with and without Down's syndrome, 1986-1991.
    Singer RB; Strauss D
    J Insur Med; 1997; 29(3):172-84. PubMed ID: 10176367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The kallikrein-kinin system of sweat in normal and cystic fibrosis subjects.
    Zucollo A; Martiarena J; Luna C; Pivetta O; Villagra A; Catanzaro O
    Agents Actions Suppl; 1992; 38 ( Pt 3)():493-8. PubMed ID: 1462883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is sweat testing for cystic fibrosis feasible in patients with down syndrome?
    Ruf K; Demerath A; Hebestreit H; Kunzmann S
    BMC Pulm Med; 2018 Jan; 18(1):8. PubMed ID: 29338740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved sweat test method for the diagnosis of cystic fibrosis.
    Carter EP; Barrett AD; Heeley AF; Kuzemko JA
    Arch Dis Child; 1984 Oct; 59(10):919-22. PubMed ID: 6497428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular diagnosis of cystic fibrosis in Indian patients--a preliminary report.
    Ashavaid TF; Dherai AJ; Kondkar AA; Raghavan R; Udani SV; Udwadia ZF; Desai D
    J Assoc Physicians India; 2003 Apr; 51():345-8. PubMed ID: 12723646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum CA 19-9 levels as a diagnostic marker in cystic fibrosis patients with borderline sweat tests.
    Augarten A; Berman H; Aviram M; Diver-Habber A; Akons H; Ben Tur L; Blau H; Kerem E; Rivlin J; Katznelson D; Szeinberg A; Kerem BS; Theodor L; Paret G; Yahav Y
    Clin Exp Med; 2003 Sep; 3(2):119-23. PubMed ID: 14598187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dermatoglyphics of schizophrenics, patients with Down's syndrome and mentally retarded males as compared with Australian Europeans using multivariate statistics.
    Singh S
    Am J Phys Anthropol; 1975 Mar; 42(2):237-40. PubMed ID: 123416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conductivity determined by a new sweat analyzer compared with chloride concentrations for the diagnosis of cystic fibrosis.
    Barben J; Ammann RA; Metlagel A; Schoeni MH;
    J Pediatr; 2005 Feb; 146(2):183-8. PubMed ID: 15689903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Micropuncture studies of the sweat formation in cystic fibrosis patients.
    Schulz IJ
    J Clin Invest; 1969 Aug; 48(8):1470-7. PubMed ID: 5796359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cystic fibrosis and Down's syndrome: not always a poor prognosis.
    Saglani S; Bush A
    Pediatr Pulmonol; 2001 Apr; 31(4):321-2. PubMed ID: 11288219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatitis among patients with cystic fibrosis: correlation with pancreatic status and genotype.
    De Boeck K; Weren M; Proesmans M; Kerem E
    Pediatrics; 2005 Apr; 115(4):e463-9. PubMed ID: 15772171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Islet autoimmunity in children with Down's syndrome.
    Gillespie KM; Dix RJ; Williams AJ; Newton R; Robinson ZF; Bingley PJ; Gale EA; Shield JP
    Diabetes; 2006 Nov; 55(11):3185-8. PubMed ID: 17065360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down's syndrome and cystic fibrosis.
    Milunsky A
    Pediatrics; 1969 May; 43(5):905-6. PubMed ID: 4238846
    [No Abstract]   [Full Text] [Related]  

  • 18. Relation of sweat chloride concentration to severity of lung disease in cystic fibrosis.
    Davis PB; Schluchter MD; Konstan MW
    Pediatr Pulmonol; 2004 Sep; 38(3):204-9. PubMed ID: 15274098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphometry of the ear in Down's syndrome subjects. A three-dimensional computerized assessment.
    Sforza C; Dellavia C; Tartaglia GM; Ferrario VF
    Int J Oral Maxillofac Surg; 2005 Jul; 34(5):480-6. PubMed ID: 16053865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic characterisation of patients with intermediate sweat chloride values: towards validation of the European diagnostic algorithm for cystic fibrosis.
    Goubau C; Wilschanski M; Skalická V; Lebecque P; Southern KW; Sermet I; Munck A; Derichs N; Middleton PG; Hjelte L; Padoan R; Vasar M; De Boeck K
    Thorax; 2009 Aug; 64(8):683-91. PubMed ID: 19318346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.